Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 a (Q54316579)
Jump to navigation
Jump to search
scientific article published in September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 a |
scientific article published in September 2012 |
Statements
Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 a (English)
1 reference
Anselm Kampik
1 reference
Marcus Kernt
1 reference
Sarah Thiele
1 reference
Aljoscha S Neubauer
1 reference
Susanna Koenig
1 reference
Christoph Hirneiss
1 reference
Christos Haritoglou
1 reference
Michael W Ulbig
1 reference
1 September 2012
1 reference
1 reference
32
1 reference
8
1 reference
1652-1663
1 reference
Identifiers
1 reference